In contrast, a study found that the migraine medicine dihydroergotamine tartrate (DHE) could cause lung cancer cell death via mitophagy and mitochondria-dependent cell apoptosis through the activation of the PINK1/Parkin pathway [499]. The gene discussed is PINK1; the disease is lung cancer.